Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
All content for UKMFA is the property of Ian and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
Dr Aseem Malhotra - Speaking At The Reform Party Conference - Full Video
UKMFA
19 minutes
4 months ago
Dr Aseem Malhotra - Speaking At The Reform Party Conference - Full Video
https://rumble.com/v6056un-ukmfa-disclaimer.html Dr. Aseem Malhotra, consultant cardiologist, spoke at the Reform Party conference on the topic of "Make Britain Healthy Again." In his presentation he made carefully considered claims regarding COVID-19 vaccines and other medical interventions. The most prominent of these claims was evidence provided by Professor Angus Dalgleish and others that it's "highly likely" the vaccines were a "significant factor" in the cancer diagnoses of members of t...
UKMFA
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
